Amesite Inc. (AMST) - Form 10-K Summary
Business Context and Reporting Period
Company: Amesite Inc.
Reporting Period: Fiscal Year ended June 30, 2025
Business Overview: Amesite is a technology company that pivoted in fiscal 2025 from an education-centric model to AI-powered solutions for the healthcare sector, specifically post-acute care. The company operates two primary product lines under the NurseMagic brand: a B2C app for individual nurses and a B2B platform for healthcare enterprises. The legacy Amesite Engage platform remains operational but is not a growth focus.
Corporate Status: Emerging Growth Company, Smaller Reporting Company, Non-Accelerated Filer.
Key Financial Metrics
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Net Revenue | $110,459 | $166,881 |
| Net Loss | $(3,617,086) | $(4,403,182) |
| Operating Expenses | $3,714,072 | $4,746,532 |
| Cash and Cash Equivalents (End of Period) | $2,333,418 | $2,071,016 |
| Total Assets | $3,097,099 | $3,314,177 |
| Stockholders' Equity | $2,738,503 | $2,515,712 |
| Shares Outstanding (June 30, 2025) | 4,572,713 | 2,542,440 |
Revenue Composition (FY 2025): B2B accounted for 76% ($83,458) and B2C accounted for 24% ($27,001) of total revenue.
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased by 34% ($56,422) year-over-year. Management attributes this to a strategic pivot away from large, cash-upfront academic deals that faced administrative barriers, toward a scalable B2C and B2B healthcare model.
- Expense Reduction: Total operating expenses decreased by $1,032,460 (22%). Significant savings were realized in General and Administrative expenses (down $430k due to board resignations and payroll cuts) and Technology/Content Development (down $383k).
- Net Loss Improvement: Net loss narrowed by approximately $786,000 compared to FY 2024, driven by cost reductions despite the revenue decline and a one-time impairment charge.
- Impairment Charge: The company recognized a $90,869 impairment loss on capitalized software related to the discontinued higher education/professional learning app.
- Capital Raise: In January 2025, the company completed a public offering, selling 1,201,667 shares for net proceeds of approximately $3.1 million.
Guidance, Outlook, Risks, and Contingencies
Going Concern Warning: The filing explicitly states there is substantial doubt about the company's ability to continue as a going concern. Management believes it may not have sufficient cash to maintain planned operations for the next twelve months. The financial statements do not include adjustments that might result from this uncertainty.
Outlook and Strategy:
- The company is focused on commercializing NurseMagic in the post-acute care market (home health, skilled nursing, hospice).
- New features include NurseMagic Teams+ and NurseMagic Enterprise (launched July 2025) with EMR integration and census-based pricing.
- Management plans to generate cash through future financing transactions, including potential common stock offerings, though success is not guaranteed.
Key Risks:
- Liquidity: History of net losses and negative operating cash flows; reliance on future equity financing.
- Regulatory: Strict compliance requirements (HIPAA, HITECH, CMS) in the healthcare sector; potential penalties for non-compliance.
- Competition: Intense competition from established EMR firms and agile AI-first entrants.
- Customer Concentration: In FY 2025, one customer accounted for 41% of revenues.
- Cybersecurity: Risks associated with managing sensitive health data; no cyber risk insurance currently held.
Investor Verification Checklist
- Cash Runway: Verify the sufficiency of the $2.43 million cash balance against current burn rates and the timeline for the next financing round.
- Revenue Sustainability: Assess the concentration risk of the single customer representing 41% of FY 2025 revenue and the stability of the new B2C/B2B healthcare revenue streams.
- Going Concern Status: Review the specific terms and probability of success for the planned financing transactions mentioned in the "Liquidity and Going Concern" note.
- Regulatory Compliance: Confirm the status of HIPAA compliance for the NurseMagic platform and any ongoing audits or regulatory inquiries.
- Dilution Risk: Evaluate the potential dilution from future equity offerings required to fund operations, given the current lack of profitability.